Skip to main content
. 2017 Jul 6;28(9):2298–2304. doi: 10.1093/annonc/mdx294

Figure 1.

Figure 1.

Genomically matched clinical trials. (A) Characterization of alterations used to genomically match patients to targeted therapy across tumor types. (B) Distribution of matching alterations by level of evidence. (C) Rate of genomic matching to clinical trials over time.